Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details Textual)

v3.10.0.1
COMMITMENTS AND CONTINGENCIES (Details Textual) - USD ($)
1 Months Ended
Mar. 06, 2018
May 17, 2017
Feb. 25, 2015
Feb. 25, 2015
Sep. 30, 2018
Description Of Contribution For Formation   Under the terms of the JV Contract, the JV Partner is required to contribute $290,000 within 30 days of formation, $435,000 12 months later and $725,000 60 months after the date of formation. The Company is required to contribute certain intellectual property to the China JV through a license.      
Purchase Commitment, Description On March 6, 2018, the Company signed a distribution agreement with Curexo Inc. for South Korea and as part of this agreement, the Company is obligated to buy a rehabilitative product from Curexo Inc. for $200,000 when this product is fully developed. It is not yet developed at September 30, 2018.        
Royalty on Sales,Percentage         1.00%
China JV [Member]          
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners   25.00%      
JV Partner [Member]          
Noncontrolling Interest, Ownership Percentage by Parent   75.00%      
Exchangable Shares [Member]          
Stock Issued During Period, Shares, Issued for Services     1,753    
Stock Transferred To Lenders     2,098    
Stock to be Reimbursed to Officers     2,134    
Stock Issued During Period, Value, Issued for Services     $ 241,185    
Stock Issued During Period, Value, New Issues       $ 210,323